OREX Financial Facts
Net loss: -19.37MInterest income: 31K
See Full Income Statement
Total current assets: 116.55M
Accounts payable and accrued expenses: 6.67M
See Full Balance Sheet
Earnings History for Orexigen Therapeutics (OREX)
|
Expand Research on OREX
| Next EPS Date | 5/7/13 *Est. | EPS Growth Rate | -355.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -30.1% | Revenue Growth Rate | 0.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/13/13 | Q412 | -$0.41 | -$0.44 | +$0.03 | $857K | $910K | N/A / N/A | N/A | -6.4% | Details | |
11/7/12  |
 |
Q312 | -$0.44 | -$0.30 | -$0.14 | $857K | $890K | N/A / N/A | N/A | +32.7% | Details |
| 8/7/12 | Q212 | -$0.25 | -$0.17 | -$0.08 | $857K | $890K | N/A / N/A | N/A | +35.7% | Details | |
| 5/9/12 |
|
Q112 | -$0.16 | -$0.12 | -$0.04 | $857K | $900K | N/A / N/A | N/A | +68.2% | Details |
| 3/8/12 |
|
Q411 | -$0.09 | -$0.10 | +$0.01 | $857K | $940K | N/A / N/A | N/A | +61.1% | Details |
| 8/8/11 |
Q211 | -$0.16 | -$0.20 | +$0.04 | $857K | $740K | N/A / N/A | N/A | +340.9% | Details | |
| 5/9/11 |
|
Q111 | -$0.24 | -$0.21 | -$0.03 | $1.83M | $640K | N/A / N/A | N/A | 0% | Details |
| 3/10/11 |
|
Q410 | -$0.24 | -$0.29 | +$0.05 | N/A | $610K | N/A / N/A | N/A | +122.9% | Details |
